Marcus Beasley

In this section
Marcus Beasley
Marcus Beasley
Marcus Beasley

PhD, MSc, BSc (Hons)

Research Fellow

About
Email Address
m.beasley@abdn.ac.uk
Office Address

Epidemiology Group,

School of Medicine, Medical Sciences and Nutrition,

Health Sciences Building (1st floor),

Foresterhill,

ABERDEEN

AB25 2ZD

School/Department
School of Medicine, Medical Sciences and Nutrition

Biography

Marcus Beasley is a research fellow with the Epidemiology Group at the University of Aberdeen. His work focuses on the epidemiology of chronic pain. He is currently working on a project to estimate the effects of population interventions for people at risk of high impact chronic pain.

He has previously worked as study coordinator on a number of research studies into chronic pain and is continuing to co-ordinate the PACFiND project. He completed a PhD by publication at the University of Aberdeen and previously gained a MSc in Psychological Research Methods and a BSc Open degree from the Open University.

Qualifications

  • PhD Epidemiology 
    2021 - University of Aberdeen 
  • MSc Psychological Research Methods 
    2012 - The Open University 
  • BSc (Hons) Open Open 
    2008 - The Open University 

Latest Publications

View My Publications

Research

Research Overview

Chronic pain (including fibromyalgia). Pain management and behaviour.

Research Areas

Applied Health Sciences

Research Specialisms

  • Epidemiology
  • Research Skills

Our research specialisms are based on the Higher Education Classification of Subjects (HECoS) which is HESA open data, published under the Creative Commons Attribution 4.0 International licence.

Current Research

What are the causes and risk factors associated with high impact chronic pain?

This research aims to find out the causes of high impact chronic pain. The findings will inform interventions to address people's individual needs.

PAtient-centred Care for Fibromyalgia: New pathway Design (PACFiND)

This project aims to find a better model of healthcare for people with fibromyalgia. This could lead to better outcomes by ensuring everyone has access to timely diagnosis and effective treatments.